ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation

Secondary or therapy-related acute myeloid leukemia (s/tAML) differs biologically from de novo disease. In general s/tAML patients have inferior outcomes after chemotherapy, compared to de novo cases and often receive allogeneic stem cell transplantation (HSCT) for consolidation. The European Leukem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Marrow Transplant
Autors principals: Jentzsch, Madlen, Grimm, Juliane, Bill, Marius, Brauer, Dominic, Backhaus, Donata, Goldmann, Karoline, Schulz, Julia, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8035074/
https://ncbi.nlm.nih.gov/pubmed/33208914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01129-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars